Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy

Chronic rhinosinusitis (CRS) is an important ENT pathology which affects about 5–12% of the general population. The treatment of CRS can be pharmacological (nasal sprays, douches, systemic antibiotics and steroids), surgical (endoscopic sinus surgery) or immunological according to established algori...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Romica Cergan, Ovidiu Nicolae Berghi, Mihai Dumitru, Daniela Vrinceanu, Felicia Manole, Crenguta Sorina Serboiu
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	biologics chronic rhinosinusitis ENT
Online Access:	https://www.mdpi.com/2075-1729/13/11/2165